Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transient corneal microcysts associated with interferon therapy.

Harvey U Fracht1, Todd J Harvey, Timothy J Bennett

  • 1Department of Ophthalmology, Penn State Milton S. Hershey Medical Center, PA 17033, USA. hfracht@psu.edu

Cornea
|April 15, 2005
PubMed
Summary

Pegylated interferon and ribavirin therapy for hepatitis C can cause temporary corneal epithelial microcysts. These eye conditions resolved after stopping the medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fundamentals of Fluorescein Angiography.

Insight (American Society of Ophthalmic Registered Nurses)·2018
Same author

Wyburn-Mason syndrome.

JAMA ophthalmology·2014
Same author

Ophthalmic imaging today: an ophthalmic photographer's viewpoint - a review.

Clinical & experimental ophthalmology·2008
See all related articles

Area of Science:

  • Ophthalmology
  • Hepatology
  • Pharmacology

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • Pegylated interferon and ribavirin were standard treatments for chronic hepatitis C.
  • Ocular side effects of systemic therapies require careful monitoring.

Observation:

  • A case report detailing a patient undergoing treatment for hepatitis C.
  • The patient developed bilateral corneal epithelial microcysts during therapy.
  • These microcysts were transient and resolved post-treatment.

Findings:

  • Corneal epithelial microcysts are a potential, albeit temporary, adverse effect of pegylated interferon and ribavirin.
  • The ocular findings were directly linked to the initiation of the antiviral therapy.

Related Experiment Videos

  • Cessation of the therapy led to the complete resolution of the microcysts.

    • Implications:

    • Highlights the importance of ophthalmologic surveillance in patients receiving interferon-based therapies.
    • Informs clinicians about a specific, reversible ocular side effect associated with hepatitis C treatment.
    • Contributes to the understanding of drug-induced ocular toxicity in the context of viral infections.